Skip to main content
SpringerLink
Log in

Mitral Valve Disease: a Comprehensive Review

  • Valvular Heart Disease (T Kiefer, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This review aims to provide a comprehensive assessment of mitral valve disease, both mitral stenosis and mitral regurgitation, starting with an overview of the valve anatomy.

Recent Findings

The advent of three-dimensional imaging has allowed a better representation of the valve anatomy. Rheumatic disease is still the number one cause of mitral stenosis worldwide and percutaneous balloon mitral valvuloplasty remains the therapy of choice when indicated and in anatomically eligible patients. Mitral regurgitation (MR) is classified as primary (i.e., lesion in the mitral apparatus) or secondary (caused by left ventricular geometrical alterations). While surgery, preferably repair, is still the recommended therapy for severe primary MR, percutaneous approaches to repair and/or replace the mitral valve are being extensively investigated.

Summary

Mitral valve disease is common. A careful understanding of mitral valve anatomy and the disease processes that affect the valve are crucial for providing optimal patient care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Van Mieghem NM, Piazza N, Anderson RH, Tzikas A, Nieman K, De Laat LE, et al. Anatomy of the mitral valvular complex and its implications for transcatheter interventions for mitral regurgitation. J Am Coll Cardiol. 2010;56(8):617–26. doi:10.1016/j.jacc.2010.04.030.

    Article  PubMed  Google Scholar 

  2. Perloff JK, Roberts WC. The mitral apparatus. Functional anatomy of mitral regurgitation. Circulation. 1972;46(2):227–39.

    Article  CAS  PubMed  Google Scholar 

  3. Anwar AM, Soliman OI, ten Cate FJ, Nemes A, McGhie JS, Krenning BJ, et al. True mitral annulus diameter is underestimated by two-dimensional echocardiography as evidenced by real-time three-dimensional echocardiography and magnetic resonance imaging. Int J Card Imaging. 2007;23(5):541–7. doi:10.1007/s10554-006-9181-9.

    Article  Google Scholar 

  4. Muresian H. The clinical anatomy of the mitral valve. Clin Anat. 2009;22(1):85–98. doi:10.1002/ca.20692.

    Article  PubMed  Google Scholar 

  5. Ho SY. Anatomy of the mitral valve. Heart. 2002;88(Suppl 4):iv5–10.

    PubMed  PubMed Central  Google Scholar 

  6. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. 2005;366(9480):155–68. doi:10.1016/S0140-6736(05)66874-2.

    Article  Google Scholar 

  7. Pressman GS, Agarwal A, Braitman LE, Muddassir SM. Mitral annular calcium causing mitral stenosis. Am J Cardiol. 2010;105(3):389–91. doi:10.1016/j.amjcard.2009.09.042.

    Article  CAS  PubMed  Google Scholar 

  8. Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA. 2003;290(21):2831–7. doi:10.1001/jama.290.21.2831.

    Article  CAS  PubMed  Google Scholar 

  9. Ruckman RN, Van Praagh R. Anatomic types of congenital mitral stenosis: report of 49 autopsy cases with consideration of diagnosis and surgical implications. Am J Cardiol. 1978;42(4):592–601.

    Article  CAS  PubMed  Google Scholar 

  10. Hugenholtz PG, Ryan TJ, Stein SW, Abelmann WH. The spectrum of pure mitral stenosis. Hemodynamic studies in relation to clinical disability. Am J Cardiol. 1962;10:773–84.

    Article  CAS  PubMed  Google Scholar 

  11. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22(1):1–23; quiz 101-2. doi:10.1016/j.echo.2008.11.029.

    Article  PubMed  Google Scholar 

  12. •• Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;63(22):e57–185. doi:10.1016/j.Jacc.2014.02.536. This report constitues the AHA/ACC recommendations for the management of patients with valvular heart disease.

    Article  PubMed  Google Scholar 

  13. •• Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. AHA/ACC focused update of the 2014 AHA/ACC guideline for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2017, 2017; doi:10.1016/j.Jacc.2017.03.011. This report is the recent (2017) AHA/ACC focused update of the valvular guidelines.

  14. Schlosshan D, Aggarwal G, Mathur G, Allan R, Cranney G. Real-time 3D transesophageal echocardiography for the evaluation of rheumatic mitral stenosis. JACC Cardiovasc Imaging. 2011;4(6):580–8. doi:10.1016/j.jcmg.2010.12.009.

    Article  PubMed  Google Scholar 

  15. Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I. Am Heart J. 1951;41(1):1–29.

    Article  CAS  PubMed  Google Scholar 

  16. Rodriguez L, Thomas JD, Monterroso V, Weyman AE, Harrigan P, Mueller LN, et al. Validation of the proximal flow convergence method. Calculation of orifice area in patients with mitral stenosis. Circulation. 1993;88(3):1157–65.

    Article  CAS  PubMed  Google Scholar 

  17. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988;60(4):299–308.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Luxereau P, Dorent R, De Gevigney G, Bruneval P, Chomette G, Delahaye G. Aetiology of surgically treated mitral regurgitation. Eur Heart J. 1991;12(Suppl B):2–4.

    Article  PubMed  Google Scholar 

  19. Anyanwu AC, Adams DH. Etiologic classification of degenerative mitral valve disease: Barlow's disease and fibroelastic deficiency. Semin Thorac Cardiovasc Surg. 2007;19(2):90–6. doi:10.1053/j.semtcvs.2007.04.002.

    Article  PubMed  Google Scholar 

  20. Carpentier A. Cardiac valve surgery—the “French correction”. J Thorac Cardiovasc Surg. 1983;86(3):323–37.

    CAS  PubMed  Google Scholar 

  21. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16(7):777–802. doi:10.1016/S0894-7317(03)00335-3.

    Article  PubMed  Google Scholar 

  22. Chen CG, Thomas JD, Anconina J, Harrigan P, Mueller L, Picard MH, et al. Impact of impinging wall jet on color Doppler quantification of mitral regurgitation. Circulation. 1991;84(2):712–20.

    Article  CAS  PubMed  Google Scholar 

  23. Marsan NA, Westenberg JJ, Ypenburg C, Delgado V, van Bommel RJ, Roes SD, et al. Quantification of functional mitral regurgitation by real-time 3D echocardiography: comparison with 3D velocity-encoded cardiac magnetic resonance. JACC Cardiovasc Imaging. 2009;2(11):1245–52. doi:10.1016/j.jcmg.2009.07.006.

    Article  PubMed  Google Scholar 

  24. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451–96. doi:10.1093/eurheartj/ehs109.

    Article  PubMed  Google Scholar 

  25. Maisano F, La Canna G, Colombo A, Alfieri O. The evolution from surgery to percutaneous mitral valve interventions: the role of the edge-to-edge technique. J Am Coll Cardiol. 2011;58(21):2174–82. doi:10.1016/j.jacc.2011.07.046.

    Article  PubMed  Google Scholar 

  26. De Backer O, Piazza N, Banai S, Lutter G, Maisano F, Herrmann HC, et al. Percutaneous transcatheter mitral valve replacement: an overview of devices in preclinical and early clinical evaluation. Circ Cardiovasc Interv. 2014;7(3):400–9. doi:10.1161/Circinterventions.114.001607.

    Article  PubMed  Google Scholar 

  27. • Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, et al. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2014;371(23):2178–88. doi:10.1056/NEJMoa1410490. This study, along with the study referenced below, showed that surgical treatment of ischemic mitral regurgitation did not provide a clinically meanigful benefit.

    Article  Google Scholar 

  28. • Michler RE, Smith PK, Parides MK, Ailawadi G, Thourani V, Moskowitz AJ, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016;374(20):1932–41. doi:10.1056/NEJMoa1602003. This study reports the 2-year outcomes of the surgical treatment of ischemic mitral regurgitation, similarly showing the lack of benefit.

    Article  Google Scholar 

  29. • Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370(1):23–32. doi:10.1056/NEJMoa1312808. This study shows no significant difference between patients who underwent mitral-valve repair and those who underwent mitral-valve replacement.

    Article  Google Scholar 

  30. Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374(4):344–53. doi:10.1056/NEJMoa1512913.

    Article  CAS  PubMed  Google Scholar 

  31. Alashi A, Mentias A, Patel K, Gillinov AM, Sabik JF, Popovic ZB, et al. Synergistic utility of brain natriuretic peptide and left ventricular global longitudinal strain in asymptomatic patients with significant primary mitral regurgitation and preserved systolic function undergoing mitral valve surgery. Circ Cardiovasc Imaging. 2016;9(7) doi:10.1161/CIRCIMAGING.115.004451.

  32. Mentias A, Naji P, Gillinov AM, Rodriguez LL, Reed G, Mihaljevic T, et al. Strain echocardiography and functional capacity in asymptomatic primary mitral regurgitation with preserved ejection fraction. J Am Coll Cardiol. 2016;68(18):1974–86. doi:10.1016/j.jacc.2016.08.030.

    Article  PubMed  Google Scholar 

  33. Mentias A, Naji P, Barr T, Gillinov AM, Rodriguez LL, Mihaljevic T, et al. Incremental prognostic utility of LV global longitudinal strain and functional capacity in asymptomatic patients with significant primary mitral regurgitation and preserved left ventricular ejection fraction undergoing rest-stress echocardiography. Circulation. 2015;132

  34. Mentias A, Patel K, Patel H, Gillinov AM, Sabik JF, Mihaljevic T, et al. Effect of pulmonary vascular pressures on long-term outcome in patients with primary mitral regurgitation. J Am Coll Cardiol. 2016;67(25):2952–61. doi:10.1016/j.jacc.2016.03.589.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Imaging, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Ave, J1-130, Cleveland, OH, 44195, USA

    Serge C. Harb & Brian P. Griffin

Authors
  1. Serge C. Harb
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian P. Griffin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brian P. Griffin.

Ethics declarations

Conflict of Interest

Serge C. Harb and Brian P. Griffin declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Valvular Heart Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Harb, S.C., Griffin, B.P. Mitral Valve Disease: a Comprehensive Review. Curr Cardiol Rep 19, 73 (2017). https://doi.org/10.1007/s11886-017-0883-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-017-0883-5

Keywords

Search

Navigation